As Luteolin reduced the levels of activated PI3K/Akt/mTOR signaling cascade, the combination of Luteolin and PI3K, Akt, or mTOR inhibitors resulted in the synergistic increase in apoptosis in Tamoxifen-resistant ER-positive breast cancer cells [124]. Here, MTOR is linked to breast carcinoma.